查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1391917

大腸桿菌菌株市場：按菌株類型、按應用、按致病性、按最終用戶、按地區

Escherichia Coli Strain Market, By Strain Type, By Application, By Pathogenicity, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

大腸桿菌菌株市場預計將從 2023 年的 19.7 億美元增加到 2030 年的 31.4 億美元，2023 年至 2030 年的年複合成長率為 6.9%。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 19.7億美元
實績資料 2018-2021 預測期 2023-2030
預測期年複合成長率 6.90% 2030年市場規模預測 31.4億美元
圖 1. 2023 年按地區分類的大腸桿菌菌株全球市場佔有率(%)
大腸桿菌菌株市場-IMG1

大腸桿菌（Escherichia coli），俗稱大腸桿菌，是一種因其多樣化的特性和在研究中的廣泛應用而具有重大科學意義的細菌菌株。這種細菌屬於腸桿菌科，常見於人類和動物的胃腸道。值得注意的是，儘管大腸桿菌通常與食物中毒和感染疾病有關，但並非所有菌株都是有害的。事實上，許多細菌菌株都是有益的，並且在消化器官系統中發揮重要作用，有助於分解食物和吸收營養。然而，也有致病性大腸桿菌，可引起多種疾病，從輕微的胃腸道疾病到尿道感染、肺炎等嚴重，甚至危及生命的溶血性​​尿毒症綜合症。大腸桿菌引起如此廣泛的疾病的能力使其成為重要的公共衛生問題。大腸桿菌的多種特性及其在健康和疾病中的作用使其成為科學研究的重要模式生物。大腸桿菌在遺傳學、生物化學和生物技術領域得到了廣泛的研究，並對這些領域的理解做出了重大貢獻。研究人員利用大腸桿菌研究細菌遺傳學、研究代謝途徑並開發新的生物技術應用。這項廣泛的研究不僅加深了我們對大腸桿菌本身的了解，而且還為更廣泛的生物過程提供了寶貴的見解。

市場動態：

生物技術研究、重組蛋白生產和藥物開發預計將在預測期內推動全球大腸桿菌菌株市場的成長。此外，工業流程預計也將在預測期內促進全球大腸桿菌菌株市場的成長。生物製藥生產、合成生物學、個人化醫療和生物修復預計將在預測期內為全球大腸桿菌市場提供成長機會。

然而，安全和生物安全問題、監管障礙、與其他微生物的競爭以及污染和交叉污染的風險預計將阻礙預測期內大腸桿菌菌株市場的成長。

本研究的主要特點

  • 本報告對全球大腸桿菌菌株進行了詳細分析，並列出了以 2022 年為基準年的預測期（2023-2030）的市場規模和年複合成長率。
  • 它還闡明了各個細分市場的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
  • 它根據公司亮點、產品系列、主要亮點、績效和策略等參數，介紹了全球大腸桿菌菌株市場的主要企業。
  • 該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、經營團隊升級、市場擴張和行銷策略做出資訊的決策。
  • 全球大腸桿菌菌株市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 透過用於全球大腸桿菌菌株市場分析的各種策略矩陣，促進了相關人員的決策。

目錄

第1章 調查目的和假設

  • 研究目標
  • 假設
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章 市場動態、法規及趨勢分析

  • 市場動態
    • 促進因素
  • 生物技術研究預計將在預測期內推動市場成長
    • 抑制因素
  • 安全和生物安全擔憂預計將阻礙預測期內的市場成長
    • 機會
  • 為精準醫療應用提供自訂大腸桿菌菌株的個人化醫療預計將帶來市場機會
  • 主要亮點
  • 監管場景
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 合併、收購和合作

第4章 大腸桿菌菌株市場－冠狀病毒(COVID-19) 大流行的影響

  • 新型冠狀病毒感染疾病（COVID-19）的流行病學
  • 供需面分析
  • 經濟影響

第5章 大腸桿菌菌株市場，依菌株類型，2018-2030 年

  • 介紹
  • 共生菌株
  • 腹瀉型
  • 腸外致病菌株
  • 泌尿系統株
  • 新生兒腦膜炎菌株
  • 其他

第6章 大腸桿菌菌株市場，依應用分類，2018-2030

  • 介紹
  • 診斷
  • 研究
  • 治療
  • 重組蛋白生產
  • 品管微生物
  • 其他

第7章 大腸桿菌菌株市場，致病性，20218-2030

  • 介紹
  • 致病性大腸桿菌
  • 非致病性大腸桿菌

第8章 大腸桿菌菌株市場，依最終使用者分類，2018-2030 年

  • 介紹
  • 研究機構
  • 診斷實驗室
  • 製藥和生物技術公司
  • 受託研究機構
  • 其他

第9章 大腸桿菌菌株市場，按地區，2018-2030

  • 介紹
  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 歐洲其他地區
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 東南亞國協
  • 澳洲
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章 競爭形勢

  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Novozymes A/S
    • QIAGEN NV
    • Promega Corporation
    • Agilent Technologies, Inc.
    • New England Biolabs, Inc.
    • Takara Bio Inc.
    • Bio-Rad Laboratories, Inc.
    • GenScript Biotech Corporation
    • Sanofi
    • Xiamen Innovax Biotech Co., Ltd

第11章章節

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6132

The escherichia coli strain market is expected to reach US$ 3.14 Bn by 2030 from US$ 1.97 Bn in 2023 and is expected to exhibit a compound annual growth rate (CAGR) of 6.9% from 2023 to 2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 1.97 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 6.90% 2030 Value Projection: US$ 3.14 Bn
Figure 1. Global Escherichia Coli Strain Market Share (%), By Region, 2023
Escherichia Coli Strain Market - IMG1

Escherichia Coli, commonly known as E. coli, is a strain of bacteria that has garnered significant scientific interest due to its diverse nature and extensive use in research. This bacterium belongs to the Enterobacteriaceae family and is typically found in the gastrointestinal tract of humans and animals. While E. coli is often associated with foodborne illnesses and infections, it's important to note that not all strains are harmful. In fact, many strains are beneficial and play a crucial role in the digestive system, aiding in the breakdown of food and absorption of nutrients. These beneficial strains also help in maintaining a healthy gut flora, which is essential for overall health.However, there are certain strains of E. coli that are pathogenic and can cause a range of illnesses, from minor gastrointestinal upset to severe conditions like urinary tract infections, pneumonia, and even life-threatening hemolytic uremic syndrome. The ability of E. coli to cause such a wide spectrum of diseases makes it a significant public health concern. E. coli's versatile nature and its role in both health and disease have made it a crucial model organism for scientific research. It is extensively studied in the fields of genetics, biochemistry, and biotechnology, contributing significantly to our understanding of these areas. Researchers use E. coli to study bacterial genetics, investigate metabolic pathways, and develop new biotechnological applications. This extensive research has not only enhanced our knowledge of E. coli itself but also provided valuable insights into broader biological processes.

Market Dynamics:

Biotechnology research, recombinant protein production and pharmaceutical development are anticipated to drive the growth of the global escherichia coli strain market over the forecast period. Moreover, industrial processes are also expected to boost the growth of the global escherichia coli strain market over the forecast period. Biopharmaceutical production, synthetic biology, personalized medicine, and bioremediation are expected to create growth opportunities for the global Escherichia Coli Strain market during the forecast period.

However, safety and biosecurity concerns, regulatory hurdles, competition from other microorganisms and contamination and cross-contamination risks are expected to hamper growth of the escherichia coli strain market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global escherichia coli strain market, and provides market size (US$ Bn ) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global escherichia coli strain market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA, Novozymes A/S, QIAGEN N.V., Promega Corporation, Agilent Technologies, Inc., New England Biolabs, Inc., Takara Bio Inc., Bio-Rad Laboratories, Inc., GenScript Biotech Corporation, Sanofi, and Xiamen Innovax Biotech Co., Ltd
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global escherichia coli strain market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global escherichia coli strain market

Detailed Segmentation:

  • Escherichia Coli Strain Market Segmentation, By Strain Type:
    • Commensal strains
    • Diarrheal strains
    • Extraintestinal pathogenic strains
    • Uropathogenic strains
    • Neonatal meningitis strains
    • Others
  • Escherichia Coli Strain Market Segmentation, By Application:
    • Diagnostics
    • Research
    • Therapeutics
    • Production of recombinant proteins
    • Quality control organisms
    • Others
  • Escherichia Coli Strain Market Segmentation, By Pathogenicity:
    • Pathogenic E. coli
    • Non-pathogenic E. coli
  • Escherichia Coli Strain Market Segmentation, By End User:
    • Research Institutes
    • Diagnostic Laboratories
    • Pharmaceutical & Biotechnology Companies
    • Contract Research Organizations
    • Others
  • Escherichia Coli Strain Market Segmentation, By Geography:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Top Companies in Escherichia Coili Strain Market:
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Novozymes A/S
    • QIAGEN N.V.
    • Promega Corporation
    • Agilent Technologies, Inc.
    • New England Biolabs, Inc.
    • Takara Bio Inc.
    • Bio-Rad Laboratories, Inc.
    • GenScript Biotech Corporation
    • Sanofi
    • Xiamen Innovax Biotech Co., Ltd

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Strain Type
    • Market Snippet, By Application
    • Market Snippet, By Pathogenicity
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Biotechnology research is expected to drive the market growth over forecast period
    • Restraints
  • Safety and biosecurity concerns is expected to hinder the market growth over forecast period
    • Opportunities
  • Personalized medicine to provide custom-made E. coli strains for precision medicine applications is expected to provide market opportunity
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Escherichia Coli Strain Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Escherichia Coli Strain Market, By Strain Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Commensal strains
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Diarrheal strains
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Extraintestinal pathogenic strains
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Uropathogenic strains
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Neonatal meningitis strains
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Escherichia Coli Strain Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Therapeutics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Production of recombinant proteins
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Quality control organisms
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Escherichia Coli Strain Market, By Pathogenicity, 20218-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%) Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Pathogenic E. coli
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
  • Non-pathogenic E. coli
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

8. Escherichia Coli Strain Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Pharmaceutical & Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Contract Research Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

9. Escherichia Coli Strain Market, By Geography, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2019 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Strain Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Pathogenicity, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Company Profile
    • Thermo Fisher Scientific Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Merck KGaA
    • Novozymes A/S
    • QIAGEN N.V.
    • Promega Corporation
    • Agilent Technologies, Inc.
    • New England Biolabs, Inc.
    • Takara Bio Inc.
    • Bio-Rad Laboratories, Inc.
    • GenScript Biotech Corporation
    • Sanofi
    • Xiamen Innovax Biotech Co., Ltd
  • Analyst Views

11. Section

  • References
  • Research Methodology
  • About us